Q1 2025 saw flat sales but strong margin gains, with EBITDA up 14% and Medical Solutions leading improvements. Engineered Solutions faced lower automotive sales but offset with materials growth and cost actions. Margin gains are expected to be sustainable, with further improvements targeted, and investments support future expansion.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.